Navigation Links
Registration Ends This Week: Fortune 500 Networking & Best Practice Sharing Conference in Florida
Date:5/28/2008

CHAPEL HILL, N.C., May 28 /PRNewswire/ -- Take advantage of quick and easy travel to the beautiful Gulf Coast to attend the 10th Annual Human Resources Conference: Leadership Development - Finding, Growing & Retaining Top Talent (view the full conference agenda at http://www3.best-in-class.com/gr163.htm ), sponsored by Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL, June 4-6, 2008, at The Ritz-Carlton Hotel, Sarasota, Fla.

Registration ends this week so sign up today at http://www3.best-in- class.com/gr145.htm . Leading companies, including 3M, Johnson & Johnson, Motorola, Hospira, Nationwide, Thomson Reuters, Genentech, The Home Depot and others, have already joined the speaker and attendee roster.

Don't allow your company to miss this networking opportunity with GLOBAL BENCHMARKING COUNCIL members, guests and representatives from Fortune 500 companies to exchange best practices and lessons learned on developing leaders, multi-generational workforces, growing talent in times of transition, strategic workforce planning, mentor and coaching programs, and more through dynamic case study presentations, themed networking breaks and events, facilitated interactive discussions.

Download last year's human capital management post-conference report at http://www3.best-in-class.com/gr166.htm -- a $750 value.

For more information on this year's working conference, contact Shelley Alfred-Watkins at 919.767.9254 or salfred-watkins@best-in-class.com.

Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL ( http://www3.best-in-class.com/gbc ) is an innovative research, benchmarking and networking service for business executives in pharmaceutical and life sciences, consumer and industrial products man
'/>"/>

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
2. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
3. Gentiva(R) Health Services Files Universal Shelf Registration Statement
4. PA Governors Occupational Safety and Health Conference Still Accepting Registrations
5. RxElite Files Registration Statement with Securities and Exchange Commission
6. Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock
7. Pearson Introduces Smart Technology for Collecting Patient Registration Information
8. FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.
9. HEI, Inc. Initiates Delisting and Deregistration of Its Shares on NASDAQ
10. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
11. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 1CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 1Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 2Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 4Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 5Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 1Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 3